Tag: Dr. Matthew Kulke Dana Farber
OncLive Features Neuroendocrine Tumors in Videos and News Articles
April 14, 2016
Chemotherapy Options in Neuroendocrine Tumors is the latest video to be released in the OncLive series on Neuroendocrine Tumors. Matthew H. Kulke, MD, Director of the Program in Neuroendocrine and Carcinoid-Tumors at Dana-Farber/Brigham and Women’s…
READ MORE
News and Notes for the Carcinoid and Neuroendocrine Tumor Community, March 2016
March 23, 2016
Breaking News from Advanced Accelerator Applications (AAA) about PRRT Treatment— Advanced Accelerator Applications announced on March 23 that the company has initiated an expanded access program (EAP) in the United States for the investigational…
READ MORE
